A 3-D-printed bionic hand is in development by a Tunisian startup that hopes to provide an affordable solar powered prosthetic for amputees and disabled people all over Africa.
The artificial hand beats traditional prosthetic devices with its capacity to be customized for youths and children who would otherwise need expensive resized models series as they grow up.
The Cure Bionics Company intends to develop a virtual game-like reality system to educate youngsters on how the artificial hand functions via physical therapy.
The 28-year-old founder Mohamed Dhaouafi, CEO and founder of Cure Bionics, planned his prototype in Souse, where he was an engineering student.
‘’One team member had a cousin who was born without a hand and whose parents couldn’t afford a prosthesis, especially as she was still growing up,’’ he said.
‘’So we decided to design a hand.’’
In 2017 at his family home, Dhaouafi launched his start-up. Many of his classmates were moving abroad to gain international experience and earn more money, but Dhaouafi chose a different path.
‘’It was like positive revenge,” he told AFP. ”I wanted to prove I could do it. I also want to leave a legacy to change people’s lives.”
Dhaouafi pointed at Tunisian hurdles that made it near impossible to buy parts from online large sales sites. There wasn’t enough funding and, he said, ‘’We lack visionaries within the state.’’
Dhaouafi combined the money he raised from sponsored competitions and seed capital an American company awarded him and managed to recruit 4 young engineers.
Now they are perfecting designs, trying out the prosthetic hand, and writing code.
‘Climb like Spiderman’
The device works with sensors attached to the arm which detect muscle movement, with AI-assisted software and interprets this movement then transmits instructions to the digits.
The bionic hand is equipped with a wrist that can turn sideways, fingers that respond to electronic impulses and bend at the joints, and a mechanical thumb.
Teaching youngsters how to use them, Cure has had to work on a virtual-reality headset, which ”gamifies” the process of physical therapy.
”Currently, for rehabilitation, children are asked to pretend to open a jar, for example, with the hand they no longer have,’’ said Dhaouafi.
‘’It takes time to succeed in activating the muscles this way. It’s not intuitive, and it’s very boring.’’
In Cure’s description, the engineer said: ‘’We get them to climb up buildings like Spiderman, with a game score to motivate them, and the doctor can follow up online from a distance.’’
Meanwhile, 3-D printing makes it easy to personalize prosthesis with a fashion accessory or ”a superhero’s outfit,’’ said Dhaouafi.
Cure hopes to take the bionic hand to the market within months within Tunisia and the rest of Africa, where over 75% of people who need them cannot access them, according to the World Health Organization.
‘’The aim is to be accessible financially but also geographically,’’ said Dhaouafi.
The anticipated substantial price of between $2,000 to $3,000 is just a fraction of bionic prostheses cost currently imported from Europe.
Cure aims at manufacturing the closest possible to end-users, where local technicians measure the patient’s and then print custom made-to-order devices.
‘’An imported prosthesis today means weeks or even months of waiting when you buy it, and again with each repair,’’ the inventor said.
The bionic hand is built from detachable parts that are easy to replace when damaged.
It could also be run with solar energy through a photovoltaic suitable for regions with unreliable electricity.
The rudimentary prosthesis 3-D printing started around a decade ago, and it’s becoming standard.
The solution is not magic since specialized medical skills are very vital, observed Jerry Evans, the Nia Technologies head, a non-profit organization from Canada that helps hospitals in Africa manufacture 3-D-printed lower extremities.
3-D printing is still in its early stages,” he said, ”but it is a major game-changer in the field of prosthetics and orthotics.”
‘’Developing countries will probably leapfrog to these technologies because the cost is much lower.’’
A New way around Drug Resistant Tuberculosis
Researchers at Purdue University have created a powerful compound that specifically tackles Tuberculosis, a leading killer worldwide.
The scientists came up with a series of inhibitors that destroy TB by targeting a protein necessary for the survival of the TB molecule.
Tuberculosis destabilizes the immunity of patients with the help of Protein Tyrosine Phosphates B (mPTPB). Their findings were published in the Journal of Medicinal Chemistry.
“The death toll from TB is particularly high because of drug-resistant strains,” said Zhong-Yin Zhang, distinguished professor and head of Purdue’s Department of Medicinal Chemistry and Molecular Pharmacology and director of Purdue Institute for Drug Discovery. “These inhibitors are part of a promising new approach to developing TB therapeutic agents with novel targets and mechanisms of action to help save more lives.”
Right now, doctors rely on antibiotic preparations to treat Tuberculosis. The problem is that many patients don’t complete their dose of antibiotics and this non-adherence leads to the development of drug resistant tuberculosis.
“We developed a platform to target mPTPB for novel anti-TB agents that builds on technologies we pioneered to modulate abnormal protein tyrosine phosphatase activity for the treatment of diseases such as cancer, diabetes and autoimmune disorders,” Zhang elaborated.
According to Zhang, the inhibitors’ have unique properties that make them incredibly useful. They have a lighter molecular weight and superior metabolic stability. They give scientists an excellent opportunity to create better treatments for Tuberculosis.
The visionary scientists are already working to patent the exciting new technology. The hunt is on for partners who will work with Purdue to further the development of the new technology. This is together with the Purdue Research Foundation Office of Technology Commercialization.
A New Era Diagnosing Parkinson’s
Scientists are on the verge of introducing a cheaper, faster, and completely painless test for Parkinson’s.
The researchers based at the University of Manchester said the new test which is already in sight, will herald a new era in diagnosing Parkinson’s disease.
A research paper published in the journal Nature Communications details the researchers’ findings that demonstrate hope in a new way of diagnosing Parkinson’s that is simple and painless – a skin swab.
The test examines compounds in the skin’s natural oil called sebum which is not the same in people who have Parkinson’s. Sebum is a protective oily layer on human skin.
“We believe that our results are an extremely encouraging step towards tests that could be used to help diagnose and monitor Parkinson’s,” explained University of Manchester Prof Perdita Barran.
“Not only is the test quick, simple and painless but it should also be extremely cost-effective because it uses existing technology that is already widely available.
“We are now looking to take our findings forwards to refine the test to improve accuracy even further and to take steps towards making this a test that can be used in the NHS and to develop more precise diagnostics and better treatment for this debilitating condition.”
The team worked with 500 sebum samples. All of them were extracted from people’s upper backs. Some of the subjects had Parkinson’s and some did not.
The scientists used mass spectrometry to isolate 10 chemical compounds that become reduced or elevated when the person has Parkinson’s.
They could diagnose people with Parkinson’s with an accuracy of 85%.
Because Parkinson’s takes so long to progress, it can take years for people to visit a doctor because the symptoms don’t become noticeable for years.
Specialists use a DaTscan to see whether the brain is losing dopamine-producing brain cells. This means that a patient is developing Parkinson’s disease.
The trouble is that there are other, more rare neurological conditions that cause the same loss of dopamine-producing brain cells. This makes the Parkinson’s diagnoses more complicated.
Around a quarter of people living with Parkinson’s in the UK were misdiagnosed with something else first, according to a survey of more than 2,000 people living with Parkinson’s in the UK.
56-year-old Daxa Kalayci is a Leicester native who has known that she was living with Parkinson’s since her diagnosis in September 2019. In the four years before that that, Kalayci had been misdiagnosed several times over.
“This test could be a game-changer for people living with Parkinson’s and searching for answers, like I was,” she quipped.
“I am so happy with this news because it will mean that in future people won’t have to experience the anxiety of multiple appointments, long waiting times and sleepless nights.
“The sooner this test is available, the better. Anything that can help people looking for a diagnosis is a bonus.”
Scientists will Soon spot Diseases and find exoplanets with super Tiny photonic devices
Researchers working in Sweden have created a microcomb capable of detecting diseases faster and making optical communications systems more efficient, among other exciting applications.
The scientists at the Chalmers University of Technology in Sweden have built the photonic device (microcomb) with the capability to produce optical frequencies on a micro resonator – a minute optical cavity.
Effectively, the microcomb is like a ruler of light that measures frequencies with extreme accuracy.
The microcomb generates an array of optical frequencies whose colors are evenly distributed, making it more or less a ruler of light that measures and produces frequencies with extreme accuracy.
The researchers used a chip to develop a new microcomb based on two micro resonators instead of one. The interaction between the two micro resonators is similar to atoms that bind together to create a diatomic molecule known as a photonic molecule.
The microcomb is a device that is readable and capable of being tuned as well as being replicated into something multiple times more efficient than the best devices available at the moment.
The results are extremely significant. “The reason why the results are important is that they represent a unique combination of characteristics, in terms of efficiency, low-power operation and control, that are unprecedented in the field,” explained PhD candidate Óskar Bjarki Helgason.
This is by no means the first time that scientists have created a microcomb on a chip, but it is definitely the first time that scientists have deployed a second micro resonator to beat many of the limitations that have never been surmounted before.
The arrangement has created a number of unique characteristics. The microcomb is so small that it can sit on the tip of a human hair and leaves relatively wide gaps between its teeth.
These wide teeth mean that engineers and researchers have massive opportunities to explore the possibilities.
The microcomb is capable of making optical communication systems vastly more efficient by replacing many lasers with a single microcomb placed in data centers.
The microcombs have great potential for use in lidar to power self-driving vehicles where they can be deployed to record distances, or to calibrate spectrographs deployed in astronomical observations.
Microcombs are also ideal for making optical clocks more accurate as well as improving health monitoring apps in mobile phones, and increasing the accuracy of diagnostic tests that rely on analyzing exhaled air.
“For the technology to be practical and find its use outside the lab, we need to co-integrate additional elements with the micro resonators, such as lasers, modulators, and control electronics,” explained Dr Victor Torres-Company, who is in charge of the Ultrafast Photonics Laboratory at Chalmers University. “This is a huge challenge, that requires maybe five to 10 years and an investment in engineering research, but I am convinced that it will happen.
“The most interesting advances and applications are the ones that we have not even conceived of yet. This will likely be enabled by the possibility of having multiple microcombs on the same chip. What could we achieve with tens of microcombs that we cannot do with one?”
Home7 months ago
Best Science Board Games
Health & Fitness8 months ago
8 Ways Technology Is Improving Your Health
Medical6 months ago
Four-Week Memory Test that could predict the Risk of Alzheimer’s
Automotive8 months ago
Everything you need to know about turbochargers
Medical5 months ago
IVF gets Better with AI
Medical8 months ago
Identifying the Sound of a Covid-19 Cough with Artificial Intelligence
Gadgets4 months ago
New to 3D Printing? Here are 7 Tips
Computers4 months ago
Scientists fold the Smallest Microchips ever from Graphene